Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | BMY | AMGN | GILD | ILMN |
| Company | Urovant Sciences Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.23 | 64.93 | 256.44 | 66.02 | 401.89 |
| High | 16.24 | 65.21 | 258.82 | 66.83 | 402.39 |
| Low | 16.21 | 64.74 | 254.67 | 65.86 | 390.52 |
| Last | 16.24 | 65.26 | 257.59 | 66.52 | 395.68 |
| Change | +0.01 | +0.82 | +2.46 | +0.75 | -6.28 |
| % Change | +0.06% | +1.27% | +0.96% | +1.14% | -1.56% |
| Volume | 1,739,000 | 4,082,125 | 431,764 | 1,526,941 | 204,433 |
| 20-Day Average Volume | 143,510 | 11,382,529 | 2,582,096 | 6,742,145 | 1,279,416 |
| Previous Close | 16.23 | 64.44 | 255.13 | 65.77 | 401.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 63.12 | 249.73 | 65.32 | 400.21 |
| 20-Day Raw Stochastic | 87.10% | 94.78% | 96.07% | 92.13% | 43.13% |
| 20-Day Relative Strength | 65.56% | 62.56% | 65.89% | 57.15% | 45.85% |
| Weighted Alpha | +6.45 | +7.43 | +12.57 | -11.01 | +23.59 |
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | 88% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | 96% Buy | 56% Buy | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +3.82% since 04/09/21 | +3.65% since 04/09/21 | +2.26% since 04/09/21 | -2.48% since 04/09/21 |
| Low | 16.20 on 03/24/21 | 62.27 on 04/12/21 | 247.09 on 04/13/21 | 64.15 on 04/13/21 | 391.00 on 04/16/21 |
| High | 16.25 on 03/25/21 | 65.20 on 04/16/21 | 258.70 on 04/16/21 | 66.78 on 04/16/21 | 408.58 on 04/14/21 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +5.01% since 03/16/21 | +7.37% since 03/16/21 | +4.01% since 03/16/21 | -6.24% since 03/16/21 |
| Low | 16.10 on 03/02/21 | 61.37 on 03/19/21 | 239.22 on 03/17/21 | 63.45 on 03/17/21 | 364.24 on 03/30/21 |
| High | 16.26 on 03/19/21 | 65.20 on 04/16/21 | 258.70 on 04/16/21 | 66.84 on 04/01/21 | 431.73 on 03/23/21 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -2.31% since 01/15/21 | +5.11% since 01/15/21 | +5.13% since 01/15/21 | +4.52% since 01/15/21 |
| Low | 16.03 on 12/30/20 | 58.63 on 03/04/21 | 220.25 on 03/04/21 | 61.39 on 02/26/21 | 364.24 on 03/30/21 |
| High | 16.26 on 03/19/21 | 67.16 on 01/19/21 | 276.69 on 01/28/21 | 69.36 on 02/05/21 | 555.77 on 02/12/21 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +6.14% since 10/16/20 | +9.46% since 10/16/20 | +7.39% since 10/16/20 | +20.54% since 10/16/20 |
| Low | 7.15 on 11/02/20 | 56.75 on 10/29/20 | 210.28 on 10/29/20 | 56.56 on 12/31/20 | 288.01 on 10/30/20 |
| High | 16.26 on 03/19/21 | 67.16 on 01/19/21 | 276.69 on 01/28/21 | 69.36 on 02/05/21 | 555.77 on 02/12/21 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 143,954,320 | 146,904,368 | 82,808,112 | 58,645,960 |
| Shares Outstanding, K | 32,743 | 2,233,928 | 575,802 | 1,259,056 | 145,900 |
| Annual Sales | 0 | 42,518,000,000 | 25,424,000,000 | 24,689,000,000 | 3,239,000,000 |
| Annual Net Income | -146,750,000 | -9,015,000,000 | 7,264,000,000 | 123,000,000 | 656,000,000 |
| Last Quarter Sales | 0 | 11,068,000,000 | 6,634,000,000 | 7,421,000,000 | 953,000,000 |
| Last Quarter Net Income | -46,800,000 | -10,027,000,000 | 1,615,000,000 | 1,551,000,000 | 257,000,000 |
| 60-Month Beta | 2.35 | 0.64 | 0.74 | 0.39 | 0.98 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.46 on 02/04/21 | 3.81 on 02/02/21 | 2.19 on 02/04/21 | 1.22 on 02/11/21 |
| Latest Earnings Date | 02/11/21 | 04/29/21 | 04/27/21 | 04/29/21 | 04/27/21 |
| Most Recent Dividend | N/A | 0.490 on 03/31/21 | 1.760 on 02/11/21 | 0.710 on 03/12/21 | N/A |
| Next Ex-Dividends Date | N/A | 03/31/21 | 05/14/21 | 03/12/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.91 | 15.04 | 9.21 | 88.46 |
